Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20368207 | 0.89 | HTR2A (0.42) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL28242719 | 0.82 | APP (0.41) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL28242604 | 0.82 | APP (0.44) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL29306702 | 0.81 | ACACB (0.39) | SMN1; SMN2GRM5 | |
| SCHEMBL28900530 | 0.81 | HTR2A (0.50) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL28896083 | 0.81 | SIGMAR1 (0.45) | HTR2AAPPSIGMAR1FFAR1CYP1A2 | |
| SCHEMBL13092394 | 0.80 | HTR2A (0.39) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL15562779 | 0.79 | HTR2A (0.38) | HTR2AAPPSIGMAR1NPSR1FFAR1 | |
| SCHEMBL25010948 | 0.79 | CYP2A6 (0.51) | CYP1A2CYP3A4CYP2C9CYP2C19GRM5 | |
| SCHEMBL614604 | 0.78 | KMT2A (0.42) | HTR2AAPPNPSR1FFAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119633864-A | Method for preparing thiophene compound by using one-pot method through double-function catalyst and catalyst used by same | 浙江大学 | 2025-03-18 | — | — | CN | claimed |
| CN-116478190-A | Boron-oxygen doped pi-extended mozzarella and synthesis method and application thereof | 天津理工大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116237081-A | Wrapped Pd-Ni bimetallic catalyst, catalyst preparation method and application | 东南大学 | 2023-06-09 | — | — | CN | claimed |
| CN-108675966-A | A kind of method that simple silver catalyzes and synthesizes bis- substitution -1,2,3- triazoles of 1,5- | 山东师范大学 | 2018-10-19 | — | — | CN | claimed |
| CN-119633864-A | Method for preparing thiophene compound by using one-pot method through double-function catalyst and catalyst used by same | 浙江大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-116237081-B | Wrapped Pd-Ni bimetallic catalyst, catalyst preparation method and application | 东南大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-114213296-B | Naphthalene series liquid crystal monomer compound containing isothiocyanato and preparation method and application thereof | 中节能万润股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-116478190-A | Boron-oxygen doped pi-extended mozzarella and synthesis method and application thereof | 天津理工大学 | 2023-07-25 | — | — | CN | disclosed |
| CN-116237081-A | Wrapped Pd-Ni bimetallic catalyst, catalyst preparation method and application | 东南大学 | 2023-06-09 | — | — | CN | disclosed |
| CN-114213296-A | Naphthalene series liquid crystal monomer compound containing isothiocyanato, and preparation method and application thereof | 中节能万润股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-106674131-B | A method of synthesis polysubstituted pyrimidine heterocyclic compound | 华南理工大学 | 2019-08-20 | — | — | CN | disclosed |
| CN-109400611-A | A kind of synthetic method of 1- vinyl -4,5- pyrrolin [1,2-a] quinoxaline compounds | 南京林业大学 | 2019-03-01 | — | — | CN | disclosed |
| CN-106632194-B | The method that Benzofurantone compound is prepared as CO source of release using iron pentacarbonyl | 陕西师范大学 | 2018-12-07 | — | — | CN | disclosed |
| CN-106398714-B | The preparation method of phenylacetylene class liquid crystal material | 深圳超多维科技有限公司 | 2018-11-30 | — | — | CN | disclosed |
| CN-108675966-A | A kind of method that simple silver catalyzes and synthesizes bis- substitution -1,2,3- triazoles of 1,5- | 山东师范大学 | 2018-10-19 | — | — | CN | disclosed |
| CN-108558753-A | The method that carbostyril compound is prepared as CO source of releases using iron pentacarbonyl | 陕西师范大学 | 2018-09-21 | — | — | CN | disclosed |
| CN-108383699-A | B-form DNA promotes the method that Sonogashira reactions prepare acetylenic ketone compound | 陕西师范大学 | 2018-08-10 | — | — | CN | disclosed |
| US-7374700-B2 | Hexenediyne derivative | ASAHI GLASS COMPANY, LIMITED (JP) | 2008-05-20 | — | — | US | disclosed |
| US-20070241310-A1 | HEXENEDIYNE DERIVATIVE | ASAHI GLASS CO., LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070241310-A1 | HEXENEDIYNE DERIVATIVE | CCNA1, CCNT1, CCND3 | HTR2A 584/4885APP 2728/4885SIGMAR1 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.